trending Market Intelligence /marketintelligence/en/news-insights/trending/RS--Aoe44W2bhnVeTpBzGA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Celsion to raise $15M in common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Celsion to raise $15M in common stock offering

Celsion Corp. is looking to raise up to $15 million in a common stock offering with Aspire Capital Fund LLC, a Chicago-based investment fund specializing in open market and direct equity investments in public companies.

Under the agreement, Aspire will buy up to 100,000 Celsion common shares per business day within a 24-month period.

In addition, Aspire may increase the number of common shares it will purchase for up to 2 million per business day.

Lawrenceville, N.J.-based Celsion develops and commercializes directed chemotherapy, DNA-mediated immunotherapy and RNA-based therapy products to treat cancer.